Danaher reaches $172.5 million settlement with shareholders over post-pandemic outlook

Danaher reached a $172.5 million settlement with shareholders who accused the diagnostics and ​life-sciences company of defrauding them by overstating ‌demand for its equipment as the worst of the COVID-19 pandemic passed.